Benjamin L. Palleiko, CHIEF EXECUTIVE OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 1,038 shares at $15.00 ($16K) on 2026-02-18, disclosed to the SEC on 2026-02-19.
Seasonal sale ($16k) by CHIEF EXECUTIVE OFFICER — this insider has traded KALV in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| KALV | SELL | 2026-05-13 | $89K | — | Filing → |
| KALV | SELL | 2026-04-20 | $193K | — | Filing → |
| KALV | SELL | 2026-03-10 | $108K | — | Filing → |